| Class |
Typical features |
Practical management |
| I |
No systemic toxicity; no significant comorbidity affecting treatment. |
Oral antibiotics + self-care; safety-net and review if not improving. |
| II |
Systemically unwell or significant comorbidity (e.g., diabetes, venous disease, chronic oedema). |
Consider IV/oral depending on severity and ability to take PO; consider SDEC/ambulatory IV. |
| III |
Marked systemic upset (e.g., tachycardia, tachypnoea, hypotension) or unstable comorbidities. |
Hospital assessment; IV antibiotics; monitor closely; exclude deep infection. |
| IV |
Sepsis or life-threatening infection (e.g., necrotising fasciitis). |
Resus + urgent senior/surgical input; broad-spectrum IV antibiotics per local policy. |
| Scenario |
First choice |
Penicillin allergy (examples) |
Notes |
| Mild–moderate cellulitis (oral) |
Flucloxacillin (PO) |
Clarithromycin (PO) (or doxycycline depending on local guidance/patient factors) |
Review if not improving within 2–3 days; course length commonly 5–7 days, extend if slow response. |
| Severe/systemically unwell (IV) |
Flucloxacillin (IV) |
IV alternative (e.g., clarithromycin/other per local guideline) |
Switch to oral when clinically improving; reassess diagnosis if deterioration. |
| Purulence/abscess suspected |
Drainage + antibiotics guided by severity |
As above |
Source control matters: fluctuance/pus → think abscess rather than “simple” cellulitis. |